Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001711279-23-000018
Filing Date
2023-04-04
Accepted
2023-04-04 16:20:06
Documents
19

Document Format Files

Seq Description Document Type Size
1 DEF 14A krys-20230403.htm   iXBRL DEF 14A 804488
6 krys-20230403_g1.jpg GRAPHIC 52753
7 krys-20230403_g2.jpg GRAPHIC 181740
8 krys-20230403_g3.jpg GRAPHIC 49969
9 krys-20230403_g4.jpg GRAPHIC 454662
10 krys-20230403_g5.jpg GRAPHIC 186618
  Complete submission text file 0001711279-23-000018.txt   3561338

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20230403.xsd EX-101.SCH 4308
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20230403_def.xml EX-101.DEF 5676
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20230403_lab.xml EX-101.LAB 8879
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20230403_pre.xml EX-101.PRE 5292
13 EXTRACTED XBRL INSTANCE DOCUMENT krys-20230403_htm.xml XML 155461
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38210 | Film No.: 23797924
SIC: 2836 Biological Products, (No Diagnostic Substances)